We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-11.58%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.5M
AUM Growth
-$25B
Cap. Flow
-$1.87B
Cap. Flow %
-9,134.72%
Top 10 Hldgs %
15.16%
Holding
3,274
New
1,834
Increased
671
Reduced
618
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 14.62%
2 Healthcare 13.9%
3 Financials 11.85%
4 Industrials 10.12%
5 Consumer Discretionary 8.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
1301
NRG Energy
NRG
$26.9B
$54 ﹤0.01%
+1,388
New +$53.1K
PPH icon
1302
VanEck Pharmaceutical ETF
PPH
$987M
$54 ﹤0.01%
+1,000
New +$60.6K
MUSA icon
1303
Murphy USA
MUSA
$11.1B
$53 ﹤0.01%
+700
New +$55.2K
NFRA icon
1304
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.02B
$53 ﹤0.01%
+1,228
New +$55.8K
LFC
1305
DELISTED
China Life Insurance Company Ltd.
LFC
$53 ﹤0.01%
+5,114
New +$54.4K
COLL icon
1306
Collegium Pharmaceutical
COLL
$1.16B
$52 ﹤0.01%
+3,067
New +$52.5K
ITUB icon
1307
Itaú Unibanco
ITUB
$91.6B
$52 ﹤0.01%
7,898
+334
+4% +$2.15K
OHI icon
1308
Omega Healthcare
OHI
$15.4B
$52 ﹤0.01%
+1,531
New +$53.1K
RFG icon
1309
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$339M
$52 ﹤0.01%
+2,000
New +$58.5K
RGLD icon
1310
Royal Gold
RGLD
$16.6B
$52 ﹤0.01%
+609
New +$46.9K
WEX icon
1311
WEX
WEX
$6.23B
$52 ﹤0.01%
+372
New +$61.2K
XLG icon
1312
Invesco S&P 500 Top 50 ETF
XLG
$10.4B
$52 ﹤0.01%
+2,900
New +$56.3K
CONE
1313
DELISTED
CyrusOne Inc Common Stock
CONE
$52 ﹤0.01%
+996
New +$56.9K
ACGL icon
1314
Arch Capital
ACGL
$37.2B
$51 ﹤0.01%
+1,941
New +$53.7K
AWR icon
1315
American States Water
AWR
$3.45B
$51 ﹤0.01%
+782
New +$50.2K
CRSP icon
1316
CRISPR Therapeutics
CRSP
$4.68B
$51 ﹤0.01%
+1,800
New +$62.6K
ENOV icon
1317
Enovis
ENOV
$1.7B
$51 ﹤0.01%
+1,427
New +$66.6K
HLIO icon
1318
Helios Technologies
HLIO
$2.56B
$51 ﹤0.01%
+1,550
New +$65.5K
PNR icon
1319
Pentair
PNR
$10.8B
$51 ﹤0.01%
+1,391
New +$56.2K
PRO
1320
DELISTED
PROS Holdings
PRO
$51 ﹤0.01%
+1,650
New +$52.3K
SBSI icon
1321
Southside Bancshares
SBSI
$974M
$51 ﹤0.01%
+1,637
New +$53.2K
SUPV
1322
Grupo Supervielle
SUPV
$842M
$51 ﹤0.01%
+5,987
New +$48.7K
UAA icon
1323
Under Armour
UAA
$3.04B
$51 ﹤0.01%
+2,941
New +$60.4K
ISBC
1324
DELISTED
Investors Bancorp, Inc.
ISBC
$51 ﹤0.01%
4,978
+978
+24% +$11.3K
AMCR
1325
DELISTED
AMCOR LTD ADR
AMCR
$51 ﹤0.01%
+1,378
New +$51

Similar funds

Glenmede Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Glenmede Trust held 3,274 positions worth $20.5M, down 100% from $25B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust withdrew a net $1.87B in Q4 2018, closing 49 positions and reducing 618 holdings. Its most notable exit was Andeavor, an estimated $48.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Cambrex Corporation worth $26.1K.

  • Glenmede Trust's largest Q4 2018 buy was Cambrex Corporation: 692,205 shares worth $26.1K.
  • Glenmede Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $75M increase.
  • Glenmede Trust's biggest Q4 2018 reduction was Genuine Parts, cutting an estimated $579M.
  • Glenmede Trust fully exited Andeavor in Q4 2018, selling an estimated $48.2M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.5M portfolio in Q4 2018.
  • Glenmede Trust opened 1,834 new positions and closed 49 in Q4 2018.
  • Glenmede Trust's portfolio value fell 100% quarter-over-quarter to $20.5M.

Based on Glenmede Trust's 13F filing for Q4 2018, filed 14 Feb 2019.